Preoperative findings and clinical outcomes
| Patient | Type IOL | Subluxation in the bag and out of the bag | PEX | Mydriasis (mm) | Preoperative VA | Postoperative VA | FU months | APPV | Age | Preoperative spherical equivalent | Postoperative spherocylinder refractive error |
| 1 | SINGLEP | IN | YES | >5 | 1.00 | 0.2 | 24 | YES | 73 | Not evaluable | +1/–1X20 |
| 2 | SINGLEP | IN | YES | <5 | 0.7 | 0.1 | 16 | YES | 78 | +1.25 | –1/+0.5X75 |
| 3 | SINGLEP | IN | YES | >5 | 0.7 | 0.2 | 18 | NO | 81 | Not evaluable | –0.75/+0.5X90 |
| 4 | SINGLEP | IN | YES | <5 | 1.00 | 0.4 | 34 | NO | 69 | Not evaluable | –1/+0.5X80 |
| 5 | SINGLEP | IN | NO | >5 | 0.6 | 0.17 | 16 | YES | 65 | Not evaluable | –2/+2X20 |
| 6 | THREEP | IN | YES | <5 | 1.00 | 1.00 | 24 | NO | 77 | Not evaluable | –1/+1X45 |
| 7 | THREEP | IN | YES | <5 | 0.7 | 0.17 | 26 | NO | 86 | Not evaluable | –1/+0.5X20 |
| 8 | THREEP | OUT | NO | >5 | 1.00 | 0.3 | 14 | NO | 75 | Not evaluable | –1/+1X180 |
| 9 | SINGLEP | IN | YES | <5 | 0.7 | 0.1 | 18 | YES | 69 | Not evaluable | –2/+2X90 |
| 10 | THREEP | OUT | NO | >5 | 0.6 | 0.2 | 16 | YES | 82 | Not evaluable | –1/+0.5X90 |
| 11 | THREEP | OUT | NO | >5 | 1.2 | 0.7 | 26 | YES | 78 | Not evaluable | –1/+0.5X80 |
| 12 | SINGLEP | IN | YES | >5 | 1.00 | 0.6 | 24 | NO | 75 | +1 | –1/+1X90 |
| 13 | SINGLEP | IN | NO | >5 | 0.6 | 0.2 | 21 | NO | 81 | Not evaluable | –1/+1X80 |
| 14 | THREEP | OUT | NO | >5 | 0.7 | 0.3 | 36 | YES | 80 | Not evaluable | –0.5/+0.5X30 |
| 15 | SINGLEP | IN | YES | <5 | 1.00 | 0.1 | 18 | NO | 75 | Not evaluable | –2/+3.5X40 |
| 16 | SINGLEP | IN | NO | >5 | 0.7 | 0.1 | 18 | NO | 72 | Not evaluable | –1/+1X20 |
| 17 | SINGLEP | IN | NO | >5 | 0.6 | 0.17 | 24 | YES | 74 | Not evaluable | –1.75/+2.5X10 |
| 18 | THREEP | OUT | NO | >5 | 1.00 | 0.7 | 24 | YES | 75 | Not evaluable | –1/+0.5X10 |
| 19 | THREEP | OUT | NO | <5 | 0.6 | 0.3 | 12 | NO | 76 | Not evaluable | –2/+2X80 |
| 20 | THREEP | IN | YES | <5 | 0.6 | 0.2 | 16 | NO | 82 | Not valuable | –2/+0.5X20 |
| 21 | THREEP | IN | NO | >5 | 1.00 | 0.2 | 12 | NO | 80 | Not evaluable | Not evaluable |
| 22 | SINGLEP | IN | NO | >5 | 0.7 | 0.1 | 22 | YES | 74 | Not evaluable | –1/+1(40) |
| 23 | THREEP | OUT | YES | <5 | 0.5 | 0.1 | 26 | NO | 78 | Not evaluable | –1/+05X60 |
| 24 | SINGLEP | IN | YES | <5 | 0.7 | 0.2 | 14 | NO | 69 | Not evaluable | –1/+1X30 |
| 25 | SINGLEP | IN | YES | <5 | 0.6 | 0.2 | 16 | NO | 81 | Not evaluable | –2/+2X20 |
| 26 | THREEP | IN | NO | >5 | 0.4 | 0.1 | 20 | YES | 73 | Not evaluable | –0.5/+0.5X10 |
| 27 | THREEP | IN | NO | >5 | 0.5 | 0.1 | 14 | YES | 71 | Not evaluable | –1/+1X10 |
| 28 | THREEP | IN | YES | <5 | 0.4 | 0.2 | 18 | NO | 85 | Not evaluable | –0.5/+0.5X30 |
| 29 | THREEP | IN | YES | <5 | 0.7 | 0.3 | 12 | NO | 79 | Not evaluable | –1/+1X20 |
| 30 | THREEP | OUT | NO | <5 | 0.5 | 0.1 | 15 | YES | 64 | Not evaluable | –0.5/+0.5X60 |
| 31 | THREEP | OUT | NO | <5 | 0.6 | 0.5 | 12 | NO | 66 | +1.75 | –0.5/+0.5X30 |
APPV, anterior vitreous vitrectomy; BSS, basic salt solution; CA, anterior chamber; CV, Vitreous chamber; EMC, cystoid macular oedema; FU, follow up; IOL, intraocular lens; IOP, intraocular pressure; PEX, pseudoexfoliation syndrome; VA, Visual acuity.